173 related articles for article (PubMed ID: 31897259)
1. A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center.
Fink RM; Mooney EV; Saseen JJ; Billups SJ
Pharm Pract (Granada); 2019; 17(4):1618. PubMed ID: 31897259
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial.
Kirwin JL; Cunningham RJ; Sequist TD
J Manag Care Pharm; 2010 Mar; 16(2):104-13. PubMed ID: 20178395
[TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
Padiyara RS; D'Souza JJ; Rihani RS
J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist-provided diabetes management and education via a telemonitoring program.
Shane-McWhorter L; McAdam-Marx C; Lenert L; Petersen M; Woolsey S; Coursey JM; Whittaker TC; Hyer C; LaMarche D; Carroll P; Chuy L
J Am Pharm Assoc (2003); 2015; 55(5):516-26. PubMed ID: 26359961
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Addition of Pharmacist Management to a Medication Assistance Program in Patients with Hypertension and Diabetes Resistant to Usual Care.
Smith AM; Hamann GL; Campbell JD; Sprabery LR
J Pharm Pract; 2022 Aug; 35(4):606-611. PubMed ID: 33739190
[TBL] [Abstract][Full Text] [Related]
6. Impact of Ambulatory Care Pharmacist-Led Management on Hemoglobin A1c Values among Patients with Uncontrolled Diabetes in a Primary Care Clinic vs Usual Care over Two Years.
Mohammad I; Poyer A; Hamoud R; George J
Innov Pharm; 2023; 14(1):. PubMed ID: 38035312
[No Abstract] [Full Text] [Related]
7. Post hoc depression analysis from a pharmacist-led diabetes trial.
Bateman MT; McCarthy C; Prioli KM; Wagner ML
Ment Health Clin; 2023 Feb; 13(1):18-24. PubMed ID: 36891480
[TBL] [Abstract][Full Text] [Related]
8. Pharmacist-led drug therapy management for hepatitis C at a federally qualified health care center.
Downes JM; Donovan A; McAdam-Marx C
J Am Pharm Assoc (2003); 2022; 62(5):1596-1605. PubMed ID: 35595639
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes Associated With a Collaborative Pharmacist-Endocrinologist Diabetes Intense Medical Management "Tune Up" Clinic in Complex Patients.
Morello CM; Christopher ML; Ortega L; Khoan J; Rotunno T; Edelman SV; Henry RR; Hirsch JD
Ann Pharmacother; 2016 Jan; 50(1):8-16. PubMed ID: 26546580
[TBL] [Abstract][Full Text] [Related]
10. Impact of Physician-Pharmacist Covisits at a Primary Care Clinic in Patients With Uncontrolled Diabetes.
Peterson J; Hinds A; Garza A; Barner J; Hill L; Nguyen M; Lai P; Gums T
J Pharm Pract; 2020 Jun; 33(3):321-325. PubMed ID: 30428760
[TBL] [Abstract][Full Text] [Related]
11. Patient-centered medical home pharmacists' impact on composite quality care measures for patients with uncontrolled type 2 diabetes.
Schwenka N; Donovan A; Franck L; Coan C; McAdam-Marx C; Shin E
J Am Pharm Assoc (2003); 2023; 63(5):1545-1552.e4. PubMed ID: 37301508
[TBL] [Abstract][Full Text] [Related]
12. Advanced Practice Pharmacists: a retrospective evaluation of the efficacy and cost of ClinicaL Pharmacist PractitionErs managing ambulatory Medicare patients in North Carolina (APPLE-NC).
Kislan MM; Bernstein AT; Fearrington LR; Ives TJ
BMC Health Serv Res; 2016 Oct; 16(1):607. PubMed ID: 27769219
[TBL] [Abstract][Full Text] [Related]
13. Comparing Clinical Outcomes of a Pharmacist-Managed Diabetes Clinic to Usual Physician-Based Care.
Schultz JL; Horner KE; McDanel DL; Miller ML; Beranek RL; Jacobsen RB; Sly NJ; Miller AC; Mascardo LA
J Pharm Pract; 2018 Jun; 31(3):268-271. PubMed ID: 28532224
[TBL] [Abstract][Full Text] [Related]
14. Pharmacists' impact on improving outcomes in patients with type 2 diabetes mellitus.
Pepper MJ; Mallory N; Coker TN; Chaki A; Sando KR
Diabetes Educ; 2012; 38(3):409-16. PubMed ID: 22523190
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist-physician collaborative care model for patients with uncontrolled type 2 diabetes in Brazil: results from a randomized controlled trial.
Aguiar PM; da Silva CHP; Chiann C; Dórea EL; Lyra DP; Storpirtis S
J Eval Clin Pract; 2018 Feb; 24(1):22-30. PubMed ID: 27452158
[TBL] [Abstract][Full Text] [Related]
16. The impact of a pharmacist-driven, collaborative practice on diabetes management in an Urban underserved population: a mixed method assessment.
Ray S; Lokken J; Whyte C; Baumann A; Oldani M
J Interprof Care; 2020; 34(1):27-35. PubMed ID: 31381470
[TBL] [Abstract][Full Text] [Related]
17. Impact of pharmacist-led care on glycaemic control of patients with uncontrolled type 2 diabetes: a randomised controlled trial in Nigeria.
David EA; Soremekun RO; Abah IO; Aderemi-Williams RI
Pharm Pract (Granada); 2021; 19(3):2402. PubMed ID: 34457094
[TBL] [Abstract][Full Text] [Related]
18. Pharmacist telehealth in an underserved urban population with type 2 diabetes mellitus.
Mukherjee SM; DelDotto D; Patel A; Silva MA
Res Social Adm Pharm; 2023 Nov; 19(11):1465-1470. PubMed ID: 37507339
[TBL] [Abstract][Full Text] [Related]
19. Impact of pharmacist intervention to improve medication access for patients with diabetes.
Bias AA; Hiday RA; Kline MM
J Am Pharm Assoc (2003); 2023; 63(4S):S25-S30. PubMed ID: 36621403
[TBL] [Abstract][Full Text] [Related]
20. Clinical inertia among health care providers in a public health safety-net clinic in the management of type 2 diabetes.
Lingow SE; Guyton JE
J Am Pharm Assoc (2003); 2020; 60(5):734-739. PubMed ID: 32280024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
